...
首页> 外文期刊>Head and neck: Journal for the sciences and specialities of the head and neck >Parotid gland lesions: diagnosis of malignancy with MRI and flow cytometric DNA analysis and cytology in fine-needle aspiration biopsy.
【24h】

Parotid gland lesions: diagnosis of malignancy with MRI and flow cytometric DNA analysis and cytology in fine-needle aspiration biopsy.

机译:腮腺病变:在细针穿刺活检中通过MRI和流式细胞仪DNA分析及细胞学诊断恶性肿瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The purpose of this study was to assess the capability of magnetic resonance imaging (MRI) and cytology and flow cytometric (FCM) deoxyribonucleic acid (DNA) analysis in fine-needle aspiration biopsy (FNAB)-derived materials for diagnosing malignancy of the parotid lesions and the efficacy of FCM analysis in FNAB. METHODS: Magnetic resonance imaging findings and FCM results (ploidy and S + G2 + M phases [S + G2M] fraction) and cytology in FNAB-derived materials in 26 patients with 26 parotid lesions (12 benign lesions, 14 malignancies) were assessed for predicting malignancy. Flow cytometric results in aspirates were compared with those in surgically resected tissues. RESULTS: When a single predictor was used, cytology (92% accuracy) was most accurate for malignancy, followed by ill-defined margin (88% accuracy) and aneuploidy (88% accuracy). The combination of FCM and cytology raised the rate of sufficient materials from 92% to 100% and accuracy from 92% to 96% compared with cytology alone. The same highest accuracy (96%) was obtained with the combination of the ill-defined margin or other findings such as cytology, aneuploidy, or a high (S + G2M) fraction (6% <). Deoxyribonucleic acid ploidy in the FNAB showed full agreement with that in the surgical specimens. Receiver operating characteristic curves showed that the diagnosis of malignancy with (S + G2M) fraction in FNAB was superior to that in surgical specimens, but no significant difference was noted. CONCLUSIONS: A combination of MRI findings, cytology, and FCM results is optimal for diagnosing malignancies of the parotid lesions, and FNAB may replace the surgical specimens in FCM analysis.
机译:背景:这项研究的目的是评估磁共振成像(MRI)和细胞学和流式细胞仪(FCM)脱氧核糖核酸(DNA)分析在细针穿刺活检(FNAB)衍生材料中诊断恶性肿瘤的能力。腮腺病变和FNAB中FCM分析的功效。方法:对26例腮腺病变(12例良性病变,14例恶性肿瘤)的26例患者的FNAB衍生材料的磁共振成像结果和FCM结果(倍性和S + G2 + M期[S + G2M]分数)和细胞学进行了评估。预测恶性肿瘤。将吸出物中的流式细胞术结果与手术切除的组织中的流式细胞术结果进行比较。结果:当使用单个预测因子时,细胞学检查(92%的准确度)对恶性肿瘤最准确,其次是不确定的切缘(88%的准确度)和非整倍性(88%的准确度)。与单独的细胞学相比,FCM和细胞学的结合将充足材料的比率从92%提高到100%,并将准确性从92%提高到96%。结合不确定的边界或其他发现(例如细胞学,非整倍性或高(S + G2M)分数(6%<)),可以达到相同的最高准确度(96%)。 FNAB中的脱氧核糖核酸倍性与手术标本完全一致。接收者的工作特征曲线表明,在FNAB中诊断为(S + G2M)分数的恶性肿瘤优于手术标本,但未发现明显差异。结论:MRI检查结果,细胞学检查和FCM结果的组合是诊断腮腺病变恶性肿瘤的最佳方法,FNAB可代替FCM分析中的手术标本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号